Sanguine Company

They are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. They believe it should be easy for patients to contribute to the advancement of research for medical conditions that matter most to them, regardless of their location or ability to travel by bringing health care professionals to the home. Their proprietary platform seamlessly integrates information from site/sponsor, mobile clinical staff, and patients, increasing efficiency, consistency, and quality for each at-home visit. Their mobile staff covers the US, Canada and Europe. Each staff is trained on specific protocols and carry credentials that are necessary in conducting clinical trial procedures at the patient's home. Through this approach, their goal is to widen patient reach for improved recruitment, decrease patient burden for improved retention, and decrease site-work effort.
Technology: Smart Home Tech
Industry: AgeTech
Headquarters: Others
Founded Date: 2010
Employees Number: 11-50
Funding Status: Seed
Investors Number: 7
Total Funding: $6M
Estimated Revenue: $1M to $10M
Last Funding Type: Venture - Series Unknown

Visit Website
info@sanguinebio.com
http://twitter.com/sanguinebio
Register and Claim Ownership